Commetric with a leading US biotech company

Commetric partnered with a leading US biotech company to enhance its media coverage analysis during quarterly earnings announcements. The company’s previous reliance on basic metrics and automated sentiment analysis led to blind spots and inefficiencies. Commetric introduced a sophisticated framework combining AI tools with human-powered analysis. This new system included a four-point sentiment scale, granular message analysis and additional metrics such as brand salience.

Over six months, this approach drove strategic changes, such as discontinuing low-impact journalist calls and aligning PR efforts with business objectives.

The new framework improved sentiment tracking, expanded media analysis to include social media and provided actionable insights, enabling the biotech company to make more informed, strategic decisions.

One judge commented: “This is a solid entry showing how to effectively create media impact reporting.”